The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement
Mark D. Stegall, Kenneth Troy Somerville, Matthew J. Everly, Roslyn B. Mannon, A. Osama Gaber, M. Roy First, Neetu Agashivala, Vanessa Perez, Kenneth A. Newell, Randall E. Morris, Debra Sudan, Klaus Romero, Sonya Eremenco, Maria Mattera, Nicole Spear, Amy C. Porter, Inish O'Doherty
Fingerprint
Dive into the research topics of 'The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement'. Together they form a unique fingerprint.